View More View Less
  • 1 Debreceni Egyetem, Orvos- és Egészségtudományi Centrum Belgyógyászati Intézet, III. Belgyógyászati Klinika, Klinikai Immunológiai Tanszék Debrecen Nagyerdei krt. 98. 4032
Restricted access

A szisztémás lupus erythematosus poliszisztémás autoimmun betegség, egyik legjelentősebb szervi szövődménye a lupus nephritis. A lupus nephritis időbeni, a krónikus szervi érintettség kialakulását megelőző felismerése, a shubok előrejelzése, a korai agresszív kezelés elkezdése és a terápia sikerességének lemérése kívánatos lenne. Ezért a kutatások egy része intenzíven a legmegfelelőbb, aktivitást előre jelző biomarker megtalálására irányul. Jelen összefoglaló célja a hagyományos szerológiai markerek megbeszélésén túl a legújabb, részben még kísérletes, a klinikai gyakorlatban nem használt, de az SLE, illetve lupus nephritis aktivitását jellemző specifikus biomarkerek bemutatása.

  • Illei, G., Lipsky, P.: Biomarkers in lupus erythematosus. Curr. Rheumatol. Rep., 2004, 6 , 382–390.

    Lipsky P. , 'Biomarkers in lupus erythematosus ' (2004 ) 6 Curr. Rheumatol. Rep. : 382 -390.

  • Szegedi G.: Az autoimmun betegségek általános jellemzése. In: Klinikai immunológia. Szerk.: Petrányi Gy. Medicina Könyvkiadó Rt., Budapest, 2000, 416–428.

    Szegedi G. , '', in Klinikai immunológia , (2000 ) -.

  • Czirják L.: Szisztémás lupus erythematosus. In: Klinikai immunológia. Szerk.: Czirják L. Medicina Könyvkiadó Zrt., Budapest, 2006, 139–156.

    Czirják L. , '', in Klinikai immunológia , (2006 ) -.

  • Hochberg, M.: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 1997, 40 , 1725.

    Hochberg M. , 'Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus ' (1997 ) 40 Arthritis Rheum. : 1725 -.

    • Search Google Scholar
  • Reyes-Thomas, J., Blanco, I., Puttermann, C.: Urinary biomarkers in lupus nephritis. Clin. Rev. Allerg. Immunol., 2010, Febr 2, Epub ahead of print.

  • Mok, C. C.: Update on emerging drug therapies for systemic lupus erythematosus. Expert Opinion on Emerging Drugs, 2010, 15 , 53–70.

    Mok C. C. , 'Update on emerging drug therapies for systemic lupus erythematosus ' (2010 ) 15 Expert Opinion on Emerging Drugs : 53 -70.

    • Search Google Scholar
  • Ward, M., Marx, A. és Barry, N.: Comparison of validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J. Rheumatol., 2000, 27 , 664–670.

    Barry N. , 'Comparison of validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus ' (2000 ) 27 J. Rheumatol. : 664 -670.

    • Search Google Scholar
  • Mok, C. C.: Biomarkers for lupus nephritis: a critical appraisal. J. Biomed. Biotech., 2010, DOI:10.1155/2010/638413 . Epub 2010 Apr 19

    Mok C. C. , 'Biomarkers for lupus nephritis: a critical appraisal ' (2010 ) J. Biomed. Biotech. : -.

    • Search Google Scholar
  • Brugos, B., Kiss, E., Szodoray, P. és mtsai: Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary. Scand. J. Immunol., 2006, 64 , 433–437.

    Szodoray P. , 'Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary ' (2006 ) 64 Scand. J. Immunol. : 433 -437.

    • Search Google Scholar
  • Wu, J., Chen, Y. és Gu, W.: Urinary proteomics as a novel tool for biomarker discovery in kidney diseases. J. Zhejiang Univ. Sci. B (Biomed. & Biotechnol.), 2010, 11 , 227–237.

    Gu W. , 'Urinary proteomics as a novel tool for biomarker discovery in kidney diseases ' (2010 ) 11 J. Zhejiang Univ. Sci. B (Biomed. & Biotechnol.) : 227 -237.

    • Search Google Scholar
  • Balow, J.: Clinical presentation and monitoring of lupus nephritis. Lupus, 2005, 14 , 25–30.

    Balow J. , 'Clinical presentation and monitoring of lupus nephritis ' (2005 ) 14 Lupus : 25 -30.

    • Search Google Scholar
  • Caiazzo, R., Maher, A., Drummond, M. és mtsai: Protein microarrays as an application for disease biomarkers. Proteomics Clin. Appl., 2009, 3 , 138–147.

    Drummond M. , 'Protein microarrays as an application for disease biomarkers ' (2009 ) 3 Proteomics Clin. Appl. : 138 -147.

    • Search Google Scholar
  • Mosley, K., Tam, F., Edwards, R., és mtsai: Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology (Oxford), 2006, 45 , 1497–1504.

    Edwards R. , 'Urinary proteomic profiles distinguish between active and inactive lupus nephritis ' (2006 ) 45 Rheumatology (Oxford) : 1497 -1504.

    • Search Google Scholar
  • Varghese, S., Powell, T., Budisavljevic, M. és mtsai: Urine biomarkers predict the cause of glomerular disease. J. Am. Soc. Nephrol., 2007, 18 , 913–922.

    Budisavljevic M. , 'Urine biomarkers predict the cause of glomerular disease ' (2007 ) 18 J. Am. Soc. Nephrol. : 913 -922.

    • Search Google Scholar
  • Oates, J., Varghese, S., Bland, A. és mtsai: Prediction of urinary protein markers in lupus nephritis. Kidney Int., 2005, 68 , 2588–2592.

    Bland A. , 'Prediction of urinary protein markers in lupus nephritis ' (2005 ) 68 Kidney Int. : 2588 -2592.

    • Search Google Scholar
  • Zhang, X., Jin, M., Wu, H. és mtsai: Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int., 2008, 74 , 799–807.

    Wu H. , 'Biomarkers of lupus nephritis determined by serial urine proteomics ' (2008 ) 74 Kidney Int. : 799 -807.

    • Search Google Scholar
  • Lee, P., Peng, H., Gelbart, T. és mtsai: Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. USA, 2005, 102 , 1906–1910.

    Gelbart T. , 'Regulation of hepcidin transcription by interleukin-1 and interleukin-6 ' (2005 ) 102 Proc. Natl. Acad. Sci. USA : 1906 -1910.

    • Search Google Scholar
  • Suzuki, M., Wiers, K., Brooks, E. és mtsai: Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr. Res., 2009, 65 , 530–536.

    Brooks E. , 'Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis ' (2009 ) 65 Pediatr. Res. : 530 -536.

    • Search Google Scholar
  • Wu, T., Fu, Y., Brekken, D. és mtsai: Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J. Immunol., 2010, 184 , 2183–2193.

    Brekken D. , 'Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis ' (2010 ) 184 J. Immunol. : 2183 -2193.

    • Search Google Scholar
  • Mishra, J., Qing, M., Prada, A. és mtsai: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol., 2003, 14 , 2534–2543.

    Prada A. , 'Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury ' (2003 ) 14 J. Am. Soc. Nephrol. : 2534 -2543.

    • Search Google Scholar
  • Brunner, H., Mueller, M., Rutherford, C. és mtsai: Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum., 2006, 54 , 2577–2584.

    Rutherford C. , 'Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus ' (2006 ) 54 Arthritis Rheum. : 2577 -2584.

    • Search Google Scholar
  • Pitashny, M., Schwartz, N., Qing, X. és mtsai: Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum., 2007, 56 , 1894–1903.

    Qing X. , 'Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis ' (2007 ) 56 Arthritis Rheum. : 1894 -1903.

    • Search Google Scholar
  • Suzuki, M., Wiers, K., Klein-Gitelman, M. és mtsai: Neutrophil-gelatinase associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr. Nephrol., 2008, 23 , 403–412.

    Klein-Gitelman M. , 'Neutrophil-gelatinase associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis ' (2008 ) 23 Pediatr. Nephrol. : 403 -412.

    • Search Google Scholar
  • Rubinstein, T., Pitashny, M. és Levine, B.: Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology, 2010, 49 , 960–971.

    Levine B. , 'Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis ' (2010 ) 49 Rheumatology : 960 -971.

    • Search Google Scholar
  • Rovin, B., Birmingham, D., Nagaraja, H. és mtsai: Biomarker discovery in human lupus nephritis. Bull. NYU J Hosp. Joint Dis., 2007, 65 , 187–193.

    Nagaraja H. , 'Biomarker discovery in human lupus nephritis ' (2007 ) 65 Bull. NYU J Hosp. Joint Dis. : 187 -193.

    • Search Google Scholar
  • Wada, T., Segawa, C., Su, S. és mtsai: Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int., 1996, 49 , 761–767.

    Su S. , 'Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis ' (1996 ) 49 Kidney Int. : 761 -767.

    • Search Google Scholar
  • Rovin, B., Song, H., Birmingham, D. és mtsai: Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J. Am. Soc. Nephrol., 2005, 16 , 467–473.

    Birmingham D. , 'Urine chemokines as biomarkers of human systemic lupus erythematosus activity ' (2005 ) 16 J. Am. Soc. Nephrol. : 467 -473.

    • Search Google Scholar
  • Ortiz, A., Sanz, A., Garcia, B. és mtsai: Considering TWEAK as a target for therapy in renal and vascular injury. Cytokine Growth Factor Reviews, 2009, 20 , 251–258.

    Garcia B. , 'Considering TWEAK as a target for therapy in renal and vascular injury ' (2009 ) 20 Cytokine Growth Factor Reviews : 251 -258.

    • Search Google Scholar
  • Gao, H., Campbell, S., Burkly, L. és mtsai: TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine, 2009, 46 , 24–35.

    Burkly L. , 'TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells ' (2009 ) 46 Cytokine : 24 -35.

    • Search Google Scholar
  • Kaplan, M., Lewia, E., Shelden, E. és mtsai: The apoptotic ligand TRAIL, TWEAK and fas ligand mediate monocyte death induced by autologous lupus T cells. J. Immunol., 2002, 169 , 6020–6029.

    Shelden E. , 'The apoptotic ligand TRAIL, TWEAK and fas ligand mediate monocyte death induced by autologous lupus T cells ' (2002 ) 169 J. Immunol. : 6020 -6029.

    • Search Google Scholar
  • Schwartz, N., Su, L., Burkly, L. és mtsai: Urinary TWEAK and the activity of lupus nephritis. J. Autoimmunity, 2006, 27 , 242–250.

    Burkly L. , 'Urinary TWEAK and the activity of lupus nephritis ' (2006 ) 27 J. Autoimmunity : 242 -250.

    • Search Google Scholar
  • Brugos, B., Kiss, E., Dul, C. és mtsai: Measurement of interleukin-1-receptor antagonist in patients with SLE could predict renal manifestation of the disease. Human Immunology, 2010, közlésre elfogadva .

  • Tsirogianni, A., Pipi, E. és Souflero, K.: Relevance of anti-C1q autoantibodies to lupus nephritis. Annals NY Acad. Sciences, 2009, 1173 , 243–251.

    Souflero K. , 'Relevance of anti-C1q autoantibodies to lupus nephritis ' (2009 ) 1173 Annals NY Acad. Sciences : 243 -251.

    • Search Google Scholar
  • Sinico, R., Radice, A., Ikehata, M. és mtsai: Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Annals NY Acad. Sciences, 2005, 1050 , 193–200.

    Ikehata M. , 'Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance ' (2005 ) 1050 Annals NY Acad. Sciences : 193 -200.

    • Search Google Scholar
  • Mészáros, T., Füst, G., Farkas, H. és mtsai: C1-inhibitor autoantibodies in SLE. Lupus, 2010, 19 , 634–638.

    Farkas H. , 'C1-inhibitor autoantibodies in SLE ' (2010 ) 19 Lupus : 634 -638.

  • Kiss E., Lakos G., Németh J. és mtsai: Significance of anti-nucleosome (anti-chromatin) auto-antibodies in systemic lupus erythematosus. Orv. Hetil., 2001, 142 , 1731–1736.

    Németh J. , 'Significance of anti-nucleosome (anti-chromatin) auto-antibodies in systemic lupus erythematosus ' (2001 ) 142 Orv. Hetil. : 1731 -1736.

    • Search Google Scholar
  • Grootscholten, C., Dieker, J., McGrath, F. és mtsai: A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Ann. Rheumatic. Dis., 2007, 66 , 693–696.

    McGrath F. , 'A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone ' (2007 ) 66 Ann. Rheumatic. Dis. : 693 -696.

    • Search Google Scholar
  • Tan, Y., Yu, F., Yang, H. és mtsai: Autoantibodies against monomeric C-reactive protein in sera from patienst with lupus nephritis are associated with disease activity and renal tubulointersticial lesions. Human Immunology, 2008, 69 , 840–844.

    Yang H. , 'Autoantibodies against monomeric C-reactive protein in sera from patienst with lupus nephritis are associated with disease activity and renal tubulointersticial lesions ' (2008 ) 69 Human Immunology : 840 -844.

    • Search Google Scholar
  • Tseng, J., Lu, L., Hu, R. és mtsai: Elevated serum antiendothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus. J. Microbiol. Immunol. Infect., 2007, 40 , 50–55.

    Hu R. , 'Elevated serum antiendothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus ' (2007 ) 40 J. Microbiol. Immunol. Infect. : 50 -55.

    • Search Google Scholar
  • Renaudineau, Y., Croquefer, S., Jousse, S. és mtsai: Association of a-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum., 2006, 8 , 2523–2532.

    Jousse S. , 'Association of a-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis ' (2006 ) 8 Arthritis Rheum. : 2523 -2532.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 0 0 1
Feb 2021 14 0 0
Mar 2021 1 1 1
Apr 2021 6 0 0
May 2021 22 0 0
Jun 2021 9 0 1
Jul 2021 0 0 0